Chemours Co Stock Performance
| CC Stock | USD 16.04 0.15 0.93% |
On a scale of 0 to 100, Chemours holds a performance score of 7. The firm shows a Beta (market volatility) of 2.63, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Chemours will likely underperform. Please check Chemours' semi deviation, jensen alpha, maximum drawdown, as well as the relationship between the coefficient of variation and sortino ratio , to make a quick decision on whether Chemours' price patterns will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Chemours Co are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain fundamental indicators, Chemours exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (0.93) | Five Day Return (0.37) | Year To Date Return 30.94 | Ten Year Return 359.6 | All Time Return (23.07) |
Forward Dividend Yield 0.0216 | Payout Ratio | Forward Dividend Rate 0.35 | Dividend Date 2025-12-15 | Ex Dividend Date 2025-11-14 |
1 | Chemours Decline Means Insider Profits Down To US49k | 11/07/2025 |
2 | Is Chemours Undervalued After Recent Downtrend A Fresh Look at Its Valuation | 11/17/2025 |
3 | How Investors Are Reacting To Chemours Appointing Michael Foley To Lead Titanium Technologies | 12/05/2025 |
| Chemours dividend paid on 15th of December 2025 | 12/15/2025 |
4 | Acquisition by Mather Courtney of 2226 shares of Chemours subject to Rule 16b-3 | 12/31/2025 |
5 | Acquisition by Satterthwaite Livingston of 1298 shares of Chemours subject to Rule 16b-3 | 01/05/2026 |
6 | Assessing Chemours Valuation After PFAS Class-Action Lawsuit Moves Forward in Montana | 01/08/2026 |
7 | FirstComm Launches AscendOne, A Unified UC CC AI Platform Transforming Business Communications | 01/13/2026 |
8 | Glycolic Acid Market is expected to generate a revenue of USD 461.74 Million by 2032, Globally, at 5.73 percent CAGR Verified Market Research | 01/14/2026 |
9 | CC to Sell Former Titanium Dioxide Taiwan Site Land for 360M | 01/16/2026 |
| Begin Period Cash Flow | 1.8 B | |
| Total Cashflows From Investing Activities | -353 M |
Chemours Relative Risk vs. Return Landscape
If you would invest 1,390 in Chemours Co on October 25, 2025 and sell it today you would earn a total of 214.00 from holding Chemours Co or generate 15.4% return on investment over 90 days. Chemours Co is generating 0.2857% of daily returns and assumes 3.2107% volatility on return distribution over the 90 days horizon. Put differently, 28% of stocks are less risky than Chemours on the basis of their historical return distribution, and some 95% of all equities are expected to be superior in generating returns on investments over the next 90 days. Expected Return |
| Risk |
Chemours Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Chemours' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Chemours Co, and traders can use it to determine the average amount a Chemours' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Based on monthly moving average Chemours is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Chemours by adding it to a well-diversified portfolio.
Chemours Fundamentals Growth
Chemours Stock prices reflect investors' perceptions of the future prospects and financial health of Chemours, and Chemours fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Chemours Stock performance.
| Return On Equity | -0.67 | |||
| Return On Asset | 0.0283 | |||
| Profit Margin | (0.05) % | |||
| Operating Margin | 0.07 % | |||
| Current Valuation | 6.23 B | |||
| Shares Outstanding | 149.89 M | |||
| Price To Earning | 25.49 X | |||
| Price To Book | 8.14 X | |||
| Price To Sales | 0.42 X | |||
| Revenue | 5.78 B | |||
| Gross Profit | 1.02 B | |||
| EBITDA | 692 M | |||
| Net Income | 86 M | |||
| Cash And Equivalents | 713 M | |||
| Cash Per Share | 7.73 X | |||
| Total Debt | 4.36 B | |||
| Debt To Equity | 2.94 % | |||
| Current Ratio | 1.82 X | |||
| Book Value Per Share | 1.99 X | |||
| Cash Flow From Operations | (633 M) | |||
| Earnings Per Share | (2.13) X | |||
| Market Capitalization | 2.43 B | |||
| Total Asset | 7.51 B | |||
| Retained Earnings | 1.72 B | |||
| Working Capital | 1.22 B | |||
| Current Asset | 2.3 B | |||
| Current Liabilities | 1.47 B | |||
About Chemours Performance
By analyzing Chemours' fundamental ratios, stakeholders can gain valuable insights into Chemours' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Chemours has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Chemours has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 104.42 | 67.65 | |
| Return On Tangible Assets | 0.01 | 0.01 | |
| Return On Capital Employed | 0.09 | 0.13 | |
| Return On Assets | 0.01 | 0.01 | |
| Return On Equity | 0.13 | 0.18 |
Things to note about Chemours performance evaluation
Checking the ongoing alerts about Chemours for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Chemours help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Chemours had very high historical volatility over the last 90 days | |
| Chemours Co reports about 713 M in cash with (633 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.73. | |
| Chemours has a poor financial position based on the latest SEC disclosures | |
| Over 95.0% of the company shares are held by institutions such as insurance companies | |
| On 15th of December 2025 Chemours paid $ 0.0875 per share dividend to its current shareholders | |
| Latest headline from zacks.com: CC to Sell Former Titanium Dioxide Taiwan Site Land for 360M |
- Analyzing Chemours' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Chemours' stock is overvalued or undervalued compared to its peers.
- Examining Chemours' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Chemours' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Chemours' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Chemours' stock. These opinions can provide insight into Chemours' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Chemours Stock analysis
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stocks Directory Find actively traded stocks across global markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |